Clinical Trial: Rapid Immune Modulating Effects

Part of paid clinical trials in Klamath Falls, Oregon.

Sponsor
Natural Immune Systems Inc
Study ID
NCT07195552
Status
Recruiting
Apply to this trial

Conditions

  • Immune Surveillance

Eligibility Criteria

Sex
ALL
Age
18 Years - 75 Years
Healthy Volunteers
Accepted

Interventions

  • Agaricus blazei — DIETARY_SUPPLEMENT
    Agaricus blazei mushroom capsules. 2000 mg per serving
  • Reishi — DIETARY_SUPPLEMENT
    Reishi mushroom capsules. 2000 mg per serving.
  • Turkey Tail — DIETARY_SUPPLEMENT
    Turkey tail mushroom capsules. 2000 mg per serving.
  • Placebo — OTHER
    Placebo

Study Details

The goal for this clinical trial is to compare the immune effects of three different medicinal mushrooms to a placebo. The mushrooms include Agaricus, Reishi, and Turkey Tail.

Key Dates

Start date
Jul 1, 2024
Status verified
Sep 2025
Primary completion
Nov 30, 2025
Completion
Dec 31, 2025

Study Design

Enrollment
12 participants (estimated)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE

Arms

  • Experimental: Crossover group 1, randomized
    Crossover study: Participants consume a test product on each of the four clinic days, at least 1 week apart, allowing for 1 week wash-out period between each product. Participants will consume each of the 3 active test products versus placebo over 4 weeks. The order of interventions for this group is A, B, C, D.
  • Experimental: Crossover group 2, randomized
    Crossover study: Participants consume a test product on each of the four clinic days, at least 1 week apart, allowing for 1 week wash-out period between each product. Participants will consume each of the 3 active test products versus placebo over 4 weeks. The order of interventions for this group is B, D, A, C.
  • Experimental: Crossover group 3, randomized
    Crossover study: Participants consume a test product on each of the four clinic days, at least 1 week apart, allowing for 1 week wash-out period between each product. Participants will consume each of the 3 active test products versus placebo over 4 weeks. The order of interventions for this group is C, A, D, B.
  • Experimental: Crossover group 4, randomized
    Crossover study: Participants consume a test product on each of the four clinic days, at least 1 week apart, allowing for 1 week wash-out period between each product. Participants will consume each of the 3 active test products versus placebo over 4 weeks. The order of interventions for this group is D, B, A, C.

Primary Outcome Measure

Immune Communication [ Time Frame: 2 hours after consuming a test product for this study protocol ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
NIS LabsKlamath FallsOregon97601
Gitte S Jensen, PhD
[email protected]
541-884-0112

Find similar trials in Klamath Falls, OR

By research site
NIS Labs· Klamath Falls, OR

Related Studies